Clinical Trials Browser

Phase 1 × Graft vs Host Disease × Rituximab × Clear all

NCT02423915 2021-01-08

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

Phase 1 Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma

NCT00473551 2011-12-19

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

Phase 1 Terminated

LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell